| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Chicago |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000259 |
Purpose
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiates, and benzodiazepine antagonists will be made. To examine sevoflurane versus isoflurane inhalation at subanesthetic concentrations on mood, pain, and psychomotor performance.
| Condition | Intervention | Phase |
|
Opioid-Related Disorders Substance-Related Disorders |
Drug: Nitrous oxide |
Phase II |
| Drug Information available for: | Sevoflurane Isoflurane Nitrous oxide |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Sevoflurane Vs Isoflurane Inhalation at Subanesthetic Concentrations |
Eligibility
| Ages Eligible for Study: | 21 Years to 39 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, Illinois | |||||
| University of Chicago, Anesthesia & Critical Care | |||||
| Chicago, Illinois, United States, 60637 | |||||
| National Institute on Drug Abuse (NIDA) |
| University of Chicago |
| Principal Investigator: | James Zacny, Ph.D. | University of Chicago |
More Information
| Study ID Numbers: | NIDA-08391-11, R01-08391-11 |
| First Received: | September 20, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000259 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
